NasdaqGS - Nasdaq Real Time Price USD
C4 Therapeutics, Inc. (CCCC)
1.5600
+0.1600
+(11.43%)
At close: April 22 at 4:00:01 PM EDT
1.5800
+0.02
+(1.28%)
Pre-Market: 4:09:56 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-65,157
-65,157
-106,838
-105,939
-86,965
Investing Cash Flow
-51,270
-51,270
158,349
58,422
-189,336
Financing Cash Flow
45,336
45,336
45,489
1,147
171,400
End Cash Position
58,942
58,942
130,033
33,033
79,403
Income Tax Paid Supplemental Data
--
--
1,003
--
--
Interest Paid Supplemental Data
--
--
990
1,624
1,308
Capital Expenditure
-180
-180
-1,708
-5,496
-1,277
Issuance of Capital Stock
44,370
44,370
57,673
--
169,465
Repayment of Debt
--
--
-12,500
--
--
Repurchase of Capital Stock
-194
-194
-110
--
--
Free Cash Flow
-65,337
-65,337
-108,546
-111,435
-88,242
12/31/2021 - 10/2/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARVN Arvinas, Inc.
8.94
+2.17%
KYMR Kymera Therapeutics, Inc.
28.80
+6.04%
NRIX Nurix Therapeutics, Inc.
11.46
+8.63%
FHTX Foghorn Therapeutics Inc.
4.2400
+8.72%
ACRV Acrivon Therapeutics, Inc.
2.0300
+6.28%
NKTX Nkarta, Inc.
2.2200
+20.00%
PRLD Prelude Therapeutics Incorporated
0.9387
+17.53%
ARQT Arcutis Biotherapeutics, Inc.
13.83
+2.22%
LXEO Lexeo Therapeutics, Inc.
3.4200
+6.54%
FATE Fate Therapeutics, Inc.
1.3700
+9.60%